Analysis in progress
Initialising…
0%
complete
This report is still being assembled — sections appear as each stage finishes. It isn't final yet.
PTEN
Final classification
VUS
PTEN c.431A>C · p.Lys144Thr
PTEN

NM_000314.8:c.431A>C (NP_000305.3:p.Lys144Thr) is a missense variant in exon 5 of PTEN.

Gene
PTEN
Transcript
NM_000314.8
HGVS · transcript:coding
NM_000314.8:c.431A>C
Consequence
N/A
GRCh38
chr10:87933190 A>C
GRCh37
chr10:89692947 A>C
Basis Richards et.al., 2015 - Combining rules v3.2.0 criteria-combination framework was evaluated deterministically with applied criteria: PM2 supporting, PP2 supporting; no rule matched the adjudicated criteria.
Richards et.al., 2015 - Combining rules v3.2.0 criteria-combination framework was evaluated deterministically with applied criteria: PM2 supporting, PP2 supporting; no rule matched the adjudicated criteria.
Classification rationale
PM2PP2 VUS
PTEN c.431A>C

NM_000314.8:c.431A>C (NP_000305.3:p.Lys144Thr) is a missense variant in exon 5 of PTEN. This variant is absent from gnomAD v2.1 and v4.1 (PM2_Supporting per VCEP).1 PTEN has a low rate of benign missense variation and missense variants are a common disease mechanism (PP2_Supporting per VCEP).2 Functional data from Mighell et al. 2018 saturation mutagenesis assay shows a cumulative fitness score of -0.15 for K144T, indicating mild functional impairment that does not meet PS3 or BS3 thresholds.3 REVEL score of 0.691 does not exceed the VCEP PP3 threshold of >0.7; SpliceAI predicts no splice impact.4 The variant lies outside the PTEN catalytic motifs (residues 90-94, 123-130, 166-168); PM1 is not met.5 This variant has been reported in ClinVar as Uncertain Significance (1 submitter, VCV2687516). It has been observed somatically in 3 cancer samples (COSMIC COSV64295211).6 No case-level proband data, de novo observations, co-segregation data, or same-residue pathogenic comparator variants were identified. With 2 supporting-level pathogenic criteria (PM2_Supporting, PP2_Supporting) and no benign criteria met, the variant does not reach the combination threshold for Likely Pathogenic or Pathogenic under the PTEN VCEP v3.2.0 rules. The variant remains a Variant of Uncertain Significance.7

PM2 + PP2 VUS
3 vcep_mmc2
4 revelspliceai ↗
7 cspec ↗final_classification_framework
Gene diagram · NM_000314.8 · variants mapped to exon structure
PTEN NM_000314.8
Fetching transcript structure from UCSC…
Applied criteria · 2 applied · 17 assessed
Applied · 2
Strength Supporting Moderate Strong Very strong
PM2 supporting Pathogenic
NM_000314.8:c.431A>C is absent from gnomAD v2.1 and v4.1. Per PTEN VCEP specification, PM2 is applied at Supporting strength when allele frequency is below 0.001%.
Absent from gnomAD v2.1 (0 alleles)Absent from gnomAD v4.1 (0 alleles)
PP2 supporting Pathogenic
NM_000314.8:c.431A>C is a missense variant in PTEN, a gene with a low rate of benign missense variation where missense variants are a common mechanism of disease, per VCEP PP2 specification.
PTEN has low rate of benign missense variationmissense variants are a common disease mechanism
Assessed · not applied
Pathogenic
PS1 No prior established pathogenic or likely pathogenic variant at amino acid residue Lys144 was identified.
PS2 No de novo observation data were identified for NM_000314.8:c.431A>C in the available evidence.
PS3 Functional data from Mighell et al.
PS4 No proband counts or phenotype specificity scores were available for this variant to calculate the VCEP PS4 specificity score.
PM1 p.Lys144 is outside the PTEN catalytic motif residues defined by the VCEP (positions 90-94, 123-130, and 166-168 in NP_000305.3).
PM5 No pathogenic or likely pathogenic missense variant at residue Lys144 was identified in ClinVar or the VCEP evidence base.
PM6 No de novo observation data were identified for NM_000314.8:c.431A>C in the available evidence.
PP1 No co-segregation data were available for this variant.
PP3 REVEL score of 0.691 does not exceed the VCEP PP3 threshold of >0.7 for missense variants.
Benign
BA1 NM_000314.8:c.431A>C is absent from gnomAD.
BS1 NM_000314.8:c.431A>C is absent from gnomAD.
BS2 No homozygous observations in healthy or PHTS-unaffected individuals were identified for this variant.
BS3 Functional data from Mighell et al.
BS4 No segregation data were available to assess lack of segregation in affected family members.
BP2 No observations of this variant in trans or cis with other PTEN pathogenic or likely pathogenic variants were available.
BP4 REVEL score of 0.691 does not meet the VCEP BP4 threshold of <0.5 for missense variants.
BP5 No evidence was identified of this variant occurring in a case with an alternate molecular basis for disease.
N/A · 7 PVS1 · PP4 · PP5 · BP1 · BP3 · BP6 · BP7
Research & evidence
Population frequency
gnomAD v4.1 screenshot
gnomAD v4.1
gnomAD v2.1 screenshot
gnomAD v2.1
v4.1
Absent from gnomAD v4.1.
v2.1
Absent from gnomAD v2.1.
🇨🇦 CA
This variant is absent from gnomAD-Canada.
Allele frequency by ancestry
three datasets · side by side
gnomAD v4.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
gnomAD v2.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
gnomAD Canada 🇨🇦
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
ClinVar screenshot
ClinVar
This variant has been reported in ClinVar as Uncertain significance (1 clinical laboratory). (ClinVarID = 2687516)
SpliceAI screenshot
In silico
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00). REVEL score = 0.691. BayesDel score = 0.0587913.
Functional / OncoKB screenshot
Functional Unknown Oncogenic Effect
OncoKB did not identify variant-specific reviewed functional evidence for this variant; gene-level curated context is available for reviewer follow-up. PTEN, a lipid and protein phosphatase, is one of the most frequently mutated genes in cancer.
OncoKB ↗
COSMIC screenshot
COSMIC
Cancer hotspots screenshot
Cancer hotspots
Somatic evidence Not in COSMIC / hotspots
COSMIC
This variant does not lie in a statistically significant hotspot. This variant has previously been reported in somatic cancers (COSMIC; COSV64295211, n = 3 times).
Hotspots
This variant does not lie in a statistically significant hotspot.
Sources & reference links
8Sources
CSpec VCEP
ClinVar
gnomAD v2.1
gnomAD v4.1
SpliceAI
OncoKB
COSMIC
Cancer hotspots
Triaged references · 3 PMIDs not cited in assessment
25394175 ↗ A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. CLINVAR
31829902 ↗ Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline. CLINVAR
35924163 ↗ Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology. CLINVAR